TP53 and liver cancer: The best mutation efficiencies for PTEN and TP53 were 74.71% and 74.68%, respectively.[14] Thus, this cynomolgus monkey model holds promise as a powerful yet feasible tool to construct human liver cancer models in adult NHPs.